— Know what they know.
Not Investment Advice

AKUS NASDAQ

Akouos, Inc.
1W: +1.0% 1M: +0.9% 3M: +296.7% 1Y: +72.8%
$13.29
Last traded 2022-11-30 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$279M -16.4% ▼
3Y CAGR: +121.1%
Total Liabilities
$45M +98.4% ▲
3Y CAGR: +11.0%
Shareholders Equity
$234M -24.8% ▼
Cash & Investments
$232M -24.5% ▼
3Y CAGR: +116.1%
Total Debt
$29M +120.5% ▲
Net Debt
-$93M -66.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021
— Assets —
Cash$23M$25M$69M$122M
Short-Term Investments$0$0$239M$111M
Cash & ST Investments$23M$25M$308M$232M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$319K$1M$3M$4M
Total Current Assets$23M$26M$311M$236M
Property, Plant & Equip.$0$0$21M$40M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$2M$19M$1M$2M
Total Non-Current Assets$2M$19M$23M$43M
Total Assets$26M$45M$333M$279M
— Liabilities —
Accounts Payable$427K$339K$895K$1M
Short-Term Debt$0$641K$1M$671K
Deferred Revenue$0$0$0$0
Other Current Liabilities$5M$5M$9M$15M
Total Current Liabilities$5M$6M$11M$17M
Long-Term Debt$0$0$12M$28M
Other Non-Current Liab.$28M$72M$0$0
Total Non-Current Liabilities$28M$72M$12M$28M
Total Liabilities$33M$78M$23M$45M
— Equity —
Common Stock$0$0$3K$3K
Retained Earnings-$7M-$33M-$82M-$168M
Accumulated OCI-$60K-$394K$13K-$202K
Total Stockholders Equity-$7M-$33M$311M$234M
Total Liabilities & Equity$26M$45M$333M$279M
— Key Metrics —
Total Debt$0$14M$13M$29M
Net Debt-$23M-$11M-$56M-$93M
Total Investments$0$0$239M$111M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms